1
Total investments
0
Early stage
0
Mid stage
1
Late stage
1y
Years active
Portfolio
1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2025
The Carolina Angel Network (CAN) brings together the UNC entrepreneurial community and the UNC alumni network to empower the early-stage new businesses that drive our future. Our mission is to support the UNC startup community with funding and advice from experienced alumni who are members of the network.
We invest in companies in which a founder, executive, or board chair is a UNC alumnus, faculty member, staff member, student, or parent.
Have questions? Take a look at our FAQs (https://www.carolinaangelnetwork.com/faqs) to learn more about Carolina Angel Network and what we do.
Experience ยท 2 entries
All (2)
Investments (1)
2025
Investor
Apr 2025
The Carolina Angel Network (CAN) brings together the UNC entrepreneurial community and the UNC alumni network to empower the early-stage new businesses that drive our future. Our mission is to support the UNC startup community with funding and advice from experienced alumni who are members of the network.
We invest in companies in which a founder, executive, or board chair is a UNC alumnus, faculty member, staff member, student, or parent.
Have questions? Take a look at our FAQs (https://www.carolinaangelnetwork.com/faqs) to learn more about Carolina Angel Network and what we do.
2011
Research Associate
Aug 2011
The Hamner Institutes for Health Sciences is a nonprofit research organization located in the heart of Research Triangle Park (RTP), N.C. The two flagship institutes at The Hamner, the Institute for Chemical Safety Sciences and the Hamner-UNC Institute for Drug Safety Sciences, build upon 35 years of preeminent research in toxicology and human health research to develop and validate new cutting-edge tools for safety assessment. Novel technologies currently being developed include in silico models for predictive toxicology, in vitro models that utilize human cells or cell lines to evaluate perturbations of cellular responses, and in vivo models to elucidate genes that play a role in susceptibility to drug-induced toxicities. The Hamner continues to grow its open, multidisciplinary campus through global partnerships with academia, industry, and government, and remains dedicated to positively impacting human health. For more information, please visit http://www.thehamner.org.
